Table of Content

1 Montelukast Drug Market Overview
1.1 Montelukast Drug Product Overview
1.2 Montelukast Drug Market Segment by Type
1.2.1 Tablets
1.2.2 Oral Granules
1.3 Global Montelukast Drug Market Size by Type
1.3.1 Global Montelukast Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Montelukast Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Montelukast Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Montelukast Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Montelukast Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Montelukast Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Montelukast Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Montelukast Drug Sales Breakdown by Type (2018-2024)
2 Global Montelukast Drug Market Competition by Company
2.1 Global Top Players by Montelukast Drug Sales (2018-2024)
2.2 Global Top Players by Montelukast Drug Revenue (2018-2024)
2.3 Global Top Players by Montelukast Drug Price (2018-2024)
2.4 Global Top Manufacturers Montelukast Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Montelukast Drug Market Competitive Situation and Trends
2.5.1 Montelukast Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Montelukast Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Montelukast Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Montelukast Drug Market
2.8 Key Manufacturers Montelukast Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Montelukast Drug Status and Outlook by Region
3.1 Global Montelukast Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Montelukast Drug Historic Market Size by Region
3.2.1 Global Montelukast Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Montelukast Drug Sales in Value by Region (2018-2024)
3.2.3 Global Montelukast Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Montelukast Drug Forecasted Market Size by Region
3.3.1 Global Montelukast Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Montelukast Drug Sales in Value by Region (2024-2029)
3.3.3 Global Montelukast Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Montelukast Drug by Application
4.1 Montelukast Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.1.3 Others
4.2 Global Montelukast Drug Market Size by Application
4.2.1 Global Montelukast Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Montelukast Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Montelukast Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Montelukast Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Montelukast Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Montelukast Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Montelukast Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Montelukast Drug Sales Breakdown by Application (2018-2024)
5 North America Montelukast Drug by Country
5.1 North America Montelukast Drug Historic Market Size by Country
5.1.1 North America Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Montelukast Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Montelukast Drug Sales in Value by Country (2018-2024)
5.2 North America Montelukast Drug Forecasted Market Size by Country
5.2.1 North America Montelukast Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Montelukast Drug Sales in Value by Country (2024-2029)
6 Europe Montelukast Drug by Country
6.1 Europe Montelukast Drug Historic Market Size by Country
6.1.1 Europe Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Montelukast Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Montelukast Drug Sales in Value by Country (2018-2024)
6.2 Europe Montelukast Drug Forecasted Market Size by Country
6.2.1 Europe Montelukast Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Montelukast Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Montelukast Drug by Region
7.1 Asia-Pacific Montelukast Drug Historic Market Size by Region
7.1.1 Asia-Pacific Montelukast Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Montelukast Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Montelukast Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Montelukast Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Montelukast Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Montelukast Drug Sales in Value by Region (2024-2029)
8 Latin America Montelukast Drug by Country
8.1 Latin America Montelukast Drug Historic Market Size by Country
8.1.1 Latin America Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Montelukast Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Montelukast Drug Sales in Value by Country (2018-2024)
8.2 Latin America Montelukast Drug Forecasted Market Size by Country
8.2.1 Latin America Montelukast Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Montelukast Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Montelukast Drug by Country
9.1 Middle East and Africa Montelukast Drug Historic Market Size by Country
9.1.1 Middle East and Africa Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Montelukast Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Montelukast Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Montelukast Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Montelukast Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Montelukast Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck & Co.
10.1.1 Merck & Co. Company Information
10.1.2 Merck & Co. Introduction and Business Overview
10.1.3 Merck & Co. Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck & Co. Montelukast Drug Products Offered
10.1.5 Merck & Co. Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Teva Montelukast Drug Products Offered
10.2.5 Teva Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Mylan Montelukast Drug Products Offered
10.3.5 Mylan Recent Development
10.4 Glenmark Pharmaceuticals
10.4.1 Glenmark Pharmaceuticals Company Information
10.4.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Glenmark Pharmaceuticals Montelukast Drug Products Offered
10.4.5 Glenmark Pharmaceuticals Recent Development
10.5 Hikma Group
10.5.1 Hikma Group Company Information
10.5.2 Hikma Group Introduction and Business Overview
10.5.3 Hikma Group Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Hikma Group Montelukast Drug Products Offered
10.5.5 Hikma Group Recent Development
10.6 Sandoz
10.6.1 Sandoz Company Information
10.6.2 Sandoz Introduction and Business Overview
10.6.3 Sandoz Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sandoz Montelukast Drug Products Offered
10.6.5 Sandoz Recent Development
10.7 Torrent Pharmaceuticals
10.7.1 Torrent Pharmaceuticals Company Information
10.7.2 Torrent Pharmaceuticals Introduction and Business Overview
10.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Torrent Pharmaceuticals Montelukast Drug Products Offered
10.7.5 Torrent Pharmaceuticals Recent Development
10.8 Lannett Company
10.8.1 Lannett Company Company Information
10.8.2 Lannett Company Introduction and Business Overview
10.8.3 Lannett Company Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Lannett Company Montelukast Drug Products Offered
10.8.5 Lannett Company Recent Development
10.9 Apotex
10.9.1 Apotex Company Information
10.9.2 Apotex Introduction and Business Overview
10.9.3 Apotex Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Apotex Montelukast Drug Products Offered
10.9.5 Apotex Recent Development
10.10 Dr. Reddys Laboratories
10.10.1 Dr. Reddys Laboratories Company Information
10.10.2 Dr. Reddys Laboratories Introduction and Business Overview
10.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Dr. Reddys Laboratories Montelukast Drug Products Offered
10.10.5 Dr. Reddys Laboratories Recent Development
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Company Information
10.11.2 Aurobindo Pharma Introduction and Business Overview
10.11.3 Aurobindo Pharma Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Aurobindo Pharma Montelukast Drug Products Offered
10.11.5 Aurobindo Pharma Recent Development
10.12 Accord Healthcare
10.12.1 Accord Healthcare Company Information
10.12.2 Accord Healthcare Introduction and Business Overview
10.12.3 Accord Healthcare Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Accord Healthcare Montelukast Drug Products Offered
10.12.5 Accord Healthcare Recent Development
10.13 Hetero
10.13.1 Hetero Company Information
10.13.2 Hetero Introduction and Business Overview
10.13.3 Hetero Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Hetero Montelukast Drug Products Offered
10.13.5 Hetero Recent Development
10.14 Unimark
10.14.1 Unimark Company Information
10.14.2 Unimark Introduction and Business Overview
10.14.3 Unimark Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Unimark Montelukast Drug Products Offered
10.14.5 Unimark Recent Development
10.15 Ajanta Pharma
10.15.1 Ajanta Pharma Company Information
10.15.2 Ajanta Pharma Introduction and Business Overview
10.15.3 Ajanta Pharma Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Ajanta Pharma Montelukast Drug Products Offered
10.15.5 Ajanta Pharma Recent Development
10.16 MACLEODS
10.16.1 MACLEODS Company Information
10.16.2 MACLEODS Introduction and Business Overview
10.16.3 MACLEODS Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 MACLEODS Montelukast Drug Products Offered
10.16.5 MACLEODS Recent Development
10.17 Jubilant Pharma
10.17.1 Jubilant Pharma Company Information
10.17.2 Jubilant Pharma Introduction and Business Overview
10.17.3 Jubilant Pharma Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Jubilant Pharma Montelukast Drug Products Offered
10.17.5 Jubilant Pharma Recent Development
10.18 Unichem Laboratories
10.18.1 Unichem Laboratories Company Information
10.18.2 Unichem Laboratories Introduction and Business Overview
10.18.3 Unichem Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Unichem Laboratories Montelukast Drug Products Offered
10.18.5 Unichem Laboratories Recent Development
10.19 Amneal Pharmaceuticals
10.19.1 Amneal Pharmaceuticals Company Information
10.19.2 Amneal Pharmaceuticals Introduction and Business Overview
10.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Amneal Pharmaceuticals Montelukast Drug Products Offered
10.19.5 Amneal Pharmaceuticals Recent Development
10.20 Shanghai Anbison Lab
10.20.1 Shanghai Anbison Lab Company Information
10.20.2 Shanghai Anbison Lab Introduction and Business Overview
10.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Shanghai Anbison Lab Montelukast Drug Products Offered
10.20.5 Shanghai Anbison Lab Recent Development
10.21 Perrigo
10.21.1 Perrigo Company Information
10.21.2 Perrigo Introduction and Business Overview
10.21.3 Perrigo Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Perrigo Montelukast Drug Products Offered
10.21.5 Perrigo Recent Development
10.22 Cipla
10.22.1 Cipla Company Information
10.22.2 Cipla Introduction and Business Overview
10.22.3 Cipla Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Cipla Montelukast Drug Products Offered
10.22.5 Cipla Recent Development
10.23 CSPC Ouyi Pharmaceutical
10.23.1 CSPC Ouyi Pharmaceutical Company Information
10.23.2 CSPC Ouyi Pharmaceutical Introduction and Business Overview
10.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
10.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Products Offered
10.23.5 CSPC Ouyi Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Montelukast Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Montelukast Drug Industrial Chain Analysis
11.4 Montelukast Drug Market Dynamics
11.4.1 Montelukast Drug Industry Trends
11.4.2 Montelukast Drug Market Drivers
11.4.3 Montelukast Drug Market Challenges
11.4.4 Montelukast Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Montelukast Drug Distributors
12.3 Montelukast Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablets
Table 2. Major Company of Oral Granules
Table 3. Global Montelukast Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Montelukast Drug Sales by Type (2018-2024) & (K Units)
Table 5. Global Montelukast Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Montelukast Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Montelukast Drug Market Share in Value by Type (2018-2024)
Table 8. Global Montelukast Drug Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Montelukast Drug Sales by Type (2024-2029) & (K Units)
Table 10. Global Montelukast Drug Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Montelukast Drug Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Montelukast Drug Sales Market Share in Value by Type (2024-2029)
Table 13. Global Montelukast Drug Price by Type (2024-2029) & (USD/Unit)
Table 14. North America Montelukast Drug Sales by Type (2018-2024) & (K Units)
Table 15. North America Montelukast Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Montelukast Drug Sales (K Units) by Type (2018-2024)
Table 17. Europe Montelukast Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Montelukast Drug Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Montelukast Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Montelukast Drug Sales (K Units) by Type (2018-2024)
Table 21. Latin America Montelukast Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Montelukast Drug Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Montelukast Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Montelukast Drug Sales by Company (2018-2024) & (K Units)
Table 25. Global Montelukast Drug Sales Share by Company (2018-2024)
Table 26. Global Montelukast Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Montelukast Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Montelukast Drug Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Montelukast Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Montelukast Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Montelukast Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Montelukast Drug Market
Table 33. Key Manufacturers Montelukast Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Montelukast Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Montelukast Drug Sales by Region (2018-2024) & (K Units)
Table 37. Global Montelukast Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Montelukast Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Montelukast Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Montelukast Drug Sales by Region (2024-2029) & (K Units)
Table 42. Global Montelukast Drug Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Montelukast Drug Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Montelukast Drug Sales Market Share in Value by Region (2024-2029)
Table 45. Global Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 46. Global Montelukast Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Montelukast Drug Sales by Application (2018-2024) & (K Units)
Table 48. Global Montelukast Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Montelukast Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Montelukast Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Montelukast Drug Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Montelukast Drug Sales by Application (2024-2029) & (K Units)
Table 53. Global Montelukast Drug Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Montelukast Drug Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Montelukast Drug Sales Market Share in Value by Application (2024-2029)
Table 56. Global Montelukast Drug Price by Application (2024-2029) & (USD/Unit)
Table 57. North America Montelukast Drug Sales by Application (2018-2024) (K Units)
Table 58. North America Montelukast Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Montelukast Drug Sales by Application (2018-2024) (K Units)
Table 60. Europe Montelukast Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Montelukast Drug Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Montelukast Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Montelukast Drug Sales by Application (2018-2024) (K Units)
Table 64. Latin America Montelukast Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Montelukast Drug Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Montelukast Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 68. North America Montelukast Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Montelukast Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Montelukast Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 72. North America Montelukast Drug Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Montelukast Drug Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Montelukast Drug Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 76. Europe Montelukast Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Montelukast Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Montelukast Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 80. Europe Montelukast Drug Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Montelukast Drug Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Montelukast Drug Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Montelukast Drug Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Montelukast Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Montelukast Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Montelukast Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Montelukast Drug Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Montelukast Drug Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Montelukast Drug Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Montelukast Drug Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Montelukast Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Montelukast Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Montelukast Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Montelukast Drug Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Montelukast Drug Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Montelukast Drug Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Montelukast Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Montelukast Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Montelukast Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Montelukast Drug Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Montelukast Drug Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Montelukast Drug Sales Market Share in Value by Country (2024-2029)
Table 107. Merck & Co. Company Information
Table 108. Merck & Co. Introduction and Business Overview
Table 109. Merck & Co. Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Merck & Co. Montelukast Drug Product
Table 111. Merck & Co. Recent Development
Table 112. Teva Company Information
Table 113. Teva Introduction and Business Overview
Table 114. Teva Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Teva Montelukast Drug Product
Table 116. Teva Recent Development
Table 117. Mylan Company Information
Table 118. Mylan Introduction and Business Overview
Table 119. Mylan Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Mylan Montelukast Drug Product
Table 121. Mylan Recent Development
Table 122. Glenmark Pharmaceuticals Company Information
Table 123. Glenmark Pharmaceuticals Introduction and Business Overview
Table 124. Glenmark Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Glenmark Pharmaceuticals Montelukast Drug Product
Table 126. Glenmark Pharmaceuticals Recent Development
Table 127. Hikma Group Company Information
Table 128. Hikma Group Introduction and Business Overview
Table 129. Hikma Group Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Hikma Group Montelukast Drug Product
Table 131. Hikma Group Recent Development
Table 132. Sandoz Company Information
Table 133. Sandoz Introduction and Business Overview
Table 134. Sandoz Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Sandoz Montelukast Drug Product
Table 136. Sandoz Recent Development
Table 137. Torrent Pharmaceuticals Company Information
Table 138. Torrent Pharmaceuticals Introduction and Business Overview
Table 139. Torrent Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Torrent Pharmaceuticals Montelukast Drug Product
Table 141. Torrent Pharmaceuticals Recent Development
Table 142. Lannett Company Company Information
Table 143. Lannett Company Introduction and Business Overview
Table 144. Lannett Company Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Lannett Company Montelukast Drug Product
Table 146. Lannett Company Recent Development
Table 147. Apotex Company Information
Table 148. Apotex Introduction and Business Overview
Table 149. Apotex Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Apotex Montelukast Drug Product
Table 151. Apotex Recent Development
Table 152. Dr. Reddys Laboratories Company Information
Table 153. Dr. Reddys Laboratories Introduction and Business Overview
Table 154. Dr. Reddys Laboratories Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Dr. Reddys Laboratories Montelukast Drug Product
Table 156. Dr. Reddys Laboratories Recent Development
Table 157. Aurobindo Pharma Company Information
Table 158. Aurobindo Pharma Introduction and Business Overview
Table 159. Aurobindo Pharma Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Aurobindo Pharma Montelukast Drug Product
Table 161. Aurobindo Pharma Recent Development
Table 162. Accord Healthcare Company Information
Table 163. Accord Healthcare Introduction and Business Overview
Table 164. Accord Healthcare Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Accord Healthcare Montelukast Drug Product
Table 166. Accord Healthcare Recent Development
Table 167. Hetero Company Information
Table 168. Hetero Introduction and Business Overview
Table 169. Hetero Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Hetero Montelukast Drug Product
Table 171. Hetero Recent Development
Table 172. Unimark Company Information
Table 173. Unimark Introduction and Business Overview
Table 174. Unimark Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. Unimark Montelukast Drug Product
Table 176. Unimark Recent Development
Table 177. Ajanta Pharma Company Information
Table 178. Ajanta Pharma Introduction and Business Overview
Table 179. Ajanta Pharma Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. Ajanta Pharma Montelukast Drug Product
Table 181. Ajanta Pharma Recent Development
Table 182. MACLEODS Company Information
Table 183. MACLEODS Introduction and Business Overview
Table 184. MACLEODS Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 185. MACLEODS Montelukast Drug Product
Table 186. MACLEODS Recent Development
Table 187. Jubilant Pharma Company Information
Table 188. Jubilant Pharma Introduction and Business Overview
Table 189. Jubilant Pharma Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 190. Jubilant Pharma Montelukast Drug Product
Table 191. Jubilant Pharma Recent Development
Table 192. Unichem Laboratories Company Information
Table 193. Unichem Laboratories Introduction and Business Overview
Table 194. Unichem Laboratories Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 195. Unichem Laboratories Montelukast Drug Product
Table 196. Unichem Laboratories Recent Development
Table 197. Amneal Pharmaceuticals Company Information
Table 198. Amneal Pharmaceuticals Introduction and Business Overview
Table 199. Amneal Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 200. Amneal Pharmaceuticals Montelukast Drug Product
Table 201. Amneal Pharmaceuticals Recent Development
Table 202. Shanghai Anbison Lab Company Information
Table 203. Shanghai Anbison Lab Introduction and Business Overview
Table 204. Shanghai Anbison Lab Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 205. Shanghai Anbison Lab Montelukast Drug Product
Table 206. Shanghai Anbison Lab Recent Development
Table 207. Perrigo Company Information
Table 208. Perrigo Introduction and Business Overview
Table 209. Perrigo Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 210. Perrigo Montelukast Drug Product
Table 211. Perrigo Recent Development
Table 212. Cipla Company Information
Table 213. Cipla Introduction and Business Overview
Table 214. Cipla Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 215. Cipla Montelukast Drug Product
Table 216. Cipla Recent Development
Table 217. CSPC Ouyi Pharmaceutical Company Information
Table 218. CSPC Ouyi Pharmaceutical Introduction and Business Overview
Table 219. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 220. CSPC Ouyi Pharmaceutical Montelukast Drug Product
Table 221. CSPC Ouyi Pharmaceutical Recent Development
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Montelukast Drug Market Trends
Table 225. Montelukast Drug Market Drivers
Table 226. Montelukast Drug Market Challenges
Table 227. Montelukast Drug Market Restraints
Table 228. Montelukast Drug Distributors List
Table 229. Montelukast Drug Downstream Customers
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Montelukast Drug Product Picture
Figure 2. Global Montelukast Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Montelukast Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Montelukast Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Tablets
Figure 6. Global Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Oral Granules
Figure 8. Global Oral Granules Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Montelukast Drug Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Montelukast Drug Sales Market Share by Type in 2022 & 2029
Figure 11. North America Montelukast Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Montelukast Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Montelukast Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Montelukast Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Montelukast Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Montelukast Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Montelukast Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Montelukast Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Montelukast Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Montelukast Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Montelukast Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Montelukast Drug Revenue in 2022
Figure 23. Montelukast Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Drug Store
Figure 27. Global Drug Store Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Montelukast Drug Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Montelukast Drug Sales Market Share by Application in 2022 & 2029
Figure 32. North America Montelukast Drug Sales Market Share in Volume by Application in 2022
Figure 33. North America Montelukast Drug Sales Market Share in Value by Application in 2022
Figure 34. Europe Montelukast Drug Sales Market Share in Volume by Application in 2022
Figure 35. Europe Montelukast Drug Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Montelukast Drug Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Montelukast Drug Sales Market Share in Value by Application in 2022
Figure 38. Latin America Montelukast Drug Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Montelukast Drug Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Montelukast Drug Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Montelukast Drug Manufacturing Cost Structure
Figure 43. Montelukast Drug Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed